Trademark applications and grants for Advantagene, Inc.. Advantagene, Inc. has 4 trademark applications. The latest application filed is for "CANDEL THERAPEUTICS"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 440 Lexington Street Auburndale, MASSACHUSETTS UNITED STATES 02466 |
Patent Application | Date |
---|---|
METHODS OF TREATING TIM-3 ELEVATION 20210369837 - 16/336207 Aguilar-Cordova; Estuardo ;   et al. | 2021-12-02 |
METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS 20190216903 - 16/365841 Aguilar-Cordova; Estuardo | 2019-07-18 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"CANDEL THERAPEUTICS" 88278673 |
CANDEL THERAPEUTICS 2019-01-28 |
"VIRAFIR" 86245573 |
VIRAFIR 2014-04-08 |
"ADVANTAGENE" 4624723 86233148 |
ADVANTAGENE 2014-03-26 |
"PROSTATAK" 4741947 86233194 |
PROSTATAK 2014-03-26 |
NCAGE Code | 47B55 | ADVANTAGENE, INC. |
CAGE Code | 47B55 | ADVANTAGENE, INC. |
S.A.M. Registration | 47B55 [192959851] | ADVANTAGENE, INC. |
SEC | 0001660549 | Advantagene, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.